HEALTH SOLUTIONS
Supplemental products
Our report on the supplement market shows the effects of COVID-19: Inforce premium rose only 1.2% to $62 billion in 2020 from 2019, but still a positive sign.
In 2019, Milliman conducted a variety of research projects to provide insight into the state of the U.S. supplemental insurance market.
This report presents the results of Milliman’s 2019 Annual Survey of the U.S. Individual Disability Income Insurance Market.
Participating insurers reported in-force premium of $19.9 billion in 2024, up 4.7% from a year earlier.
Small companies in the supplemental health products market need to understand the unique challenges these products present in order to compete effectively.
This report characterizes the costs to cancer patients and their health plans for three cancers: breast, lung, and colorectal.
The Medicare Access and CHIP Reauthorization Act of 2015 affects the Medicare Supplement industry in calendar year 2020. Learn about how things will change and the potential impact of rating practices on costs.
